
PIONEER MEIZHENG BIO-TECH (5 in 1) JC0726 / Rapid tests for determining the residual amount of Bacitracin, ansamycins, clindamycin, spiramycin, florfenicol in milk, whey
PIONEER MEIZHENG BIO-TECH (5 in1) JC0871/ Rapid tests for the determination of the residual amount of β-lactams, tetracyclines, chloramphenicol, streptomycins, ceftiofur in milk, whey.Key points:
Company comment:
Cherkizovo noted that the decline in prices for poultry products, rising costs and the high cost of borrowed capital had a negative impact on financial results. The company plans to focus on developing sales of branded products, the Foodservice and Export channels, as well as optimizing costs and increasing production efficiency.
Financial indicators:
Indicator 3 months 2025 3 months 2024 Change, % Revenue, RUB million 65,386 58,792 11.2 Gross profit, RUB million 13,938 13,740 1.4 EBITDA, RUB million 8,289 9,143 -9.0 Net profit, RUB million (786) 2,969 n/a Net debt, RUB million 146,315 103,805 41.0Factors that influenced the results:
Plans for the future:
Cherkizovo plans to focus on increasing sales of high-value-added products from turkey and pork, developing the Foodservice and Export channels, as well as optimizing costs and increasing production efficiency. The company also intends to implement an integrated solution based on 1C:ERP to improve the efficiency of all business segments.
Key findings:
Cherkizovo Group faced financial difficulties in the first quarter of 2025, despite the growth of production and revenue. The main reasons for the losses were the increase in cost price, high interest expenses and the decrease in prices for chicken meat. The company plans to take measures to improve financial performance, focusing on the development of promising areas and cost optimization.